About Us:

David Snow, Interim Non-executive Chairman

David was involved in the money and derivatives markets for 20 years, starting at Cayzer Limited before joining Harlow Butler. Until 1999 he was Chief Executive of Harlow Butler UK Limited and Garban Europe Limited, where he was responsible for approximately 500 brokers (money markets, capital markets and foreign exchange) and 100 back office staff. He prepared Garban Europe Limited for a successful stock market float (a year later the company merged with ICAP). Since then he has developed his private interests which include property, printing, security and farming. David was a non- executive director of Blue Oar from June 2007 to 5 December 2008.

Graham Lay, Chief Executive Officer

Experienced within both blue chip and early stage start-up businesses, previous roles included Senior Vice President of Johnson and Johnson Medical, General Manager of Nexan Ltd (High Tech Medical Device start up), CEO of consultancy business (LCMS) providing due diligence and business assessments to venture capitalists and businesses considering investments.

Earlier roles include worldwide Vice President R&D of Johnson and Johnson Medical, responsible for development groups within both the US and Europe. This included responsibility for the development and introduction of a new range of blood pressure monitors that remain world leaders in their class today. Roles within Johnson and Johnson included European responsibility for regulatory, clinical and technical for the CRITIKON (Johnson and Johnson) Franchise.

Graham also has experience in brand management and was an integral part of new product development and sourcing both within Europe and the rest of the world. His experience includes timely project planning and completion, worldwide quality systems, and manufacturing cost optimisation activities.

Oliver Cooke, Chief Finance Officer

Oliver is a Chartered Accountant and has over 30 years of financial and business development experience gained in a range of quoted and private companies. He also currently holds the post of Executive Chairman of St Helens Capital Partners LLP, a corporate finance boutique and the largest PLUS Market Corporate Advisor by number of clients.

Oliver’s most recent public company role was as Executive Chairman of AIM-listed Multi Group Plc. When he joined the business in 2003 it was heavily loss making and had a market capitalisation of circa £2.5 million. At the time of his departure in 2007 the business has been fully restructured, had moved into a new market sector and its market capitalisation had grown to circa £18.4 million.

Management Team

CarieScan Limited